Literature DB >> 1988226

Isotype distribution of mucosal IgG-producing cells in patients with various IgG subclass deficiencies.

D E Nilssen1, R Söderström, P Brandtzaeg, K Kett, L Helgeland, G Karlsson, T Söderström, L A Hanson.   

Abstract

The subclass distribution of IgG-producing immunocytes was examined by immunohistochemistry in nasal and rectal mucosa of infection-prone patients with untreated IgG subclass deficiencies. Biopsy specimens from the two sites were obtained in 18 clinically and serologically well-characterized adult subjects; only a nasal or rectal sample was available from nine similar patients. Chronic lung disease was common in the patient groups with selective serum IgG1 deficiency and combined IgG1 and IgG3 deficiency, whereas the other categories of patients had mainly upper airway and other mild infections. Serum IgG2 or IgG3 deficiency was usually expressed also at the cellular level in rectal mucosa, and the proportion of rectal IgG1 cells was significantly correlated with the IgG1 level (r = 0.90, P less than 0.001). Likewise, there tended to be a decreased expression of the actual subclass at the cellular level in nasal mucosa of patients with serum IgG1 or IgG2 deficiency. Conversely, the median nasal proportion of IgG3 cells was remarkably unaffected by a deficiency of this subclass in serum and rectal mucosa. Interestingly, these patients rather tended to have raised IgG3 and reduced IgG2 cell proportions in their nasal mucosa, although this apparent local IgG3 compensation was nevertheless strongly correlated with the serum IgG3 level (r = 0.87, P less than 0.002). These disparities may reflect different antigenic and mitogenic exposure of the two tissue sites; for example, a persistent protein bombardment of the nasal mucosa that could conceivably override locally a B cell maturation defect. The possible clinical consequences of such variable mucosal expression of IgG subclass deficiencies remain to be studied.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988226      PMCID: PMC1535469          DOI: 10.1111/j.1365-2249.1991.tb05581.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes.

Authors:  P Brandtzaeg; S T Gjeruldsen; F Korsrud; K Baklien; P Berdal; J Ek
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  Immune exclusion is a function of IgA.

Authors:  C R Stokes; J F Soothill; M W Turner
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

3.  Terminally differentiated human intestinal B cells. IgA and IgG subclass-producing immunocytes in the distal ileum, including Peyer's patches, compared with lymph nodes and palatine tonsils.

Authors:  K Bjerke; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1990-08       Impact factor: 3.487

4.  Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls.

Authors:  M G Scott; M H Nahm; K Macke; G S Nash; M J Bertovich; R P MacDermott
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

5.  Clinical and immunological evaluation of patients low in single or multiple IgG subclasses.

Authors:  T Söderström; R Söderström; U Bengtsson; J Björkander; K Hellstrand; J Holm; L A Hanson
Journal:  Monogr Allergy       Date:  1986

6.  Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis.

Authors:  J Björkander; U Bengtsson; V A Oxelius; L A Hanson
Journal:  Monogr Allergy       Date:  1986

7.  Quantitative determination of immunoglobulins in nasal secretion.

Authors:  N Mygind; B Weeke; S Ullman
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

8.  Raised number of jejunal IgG2-producing cells in untreated adult coeliac disease compared with food allergy.

Authors:  T O Rognum; K Kett; O Fausa; U Bengtsson; A Kilander; H Scott; P I Gaarder; P Brandtzaeg
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

9.  The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa.

Authors:  P Brandtzaeg; G Karlsson; G Hansson; B Petruson; J Björkander; L A Hanson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

10.  IgG3 deficiency: common in obstructive lung disease. Hereditary in families with immunodeficiency and autoimmune disease.

Authors:  V A Oxelius; L A Hanson; J Björkander; L Hammarström; A Sjöholm
Journal:  Monogr Allergy       Date:  1986
View more
  6 in total

1.  IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.

Authors:  L Helgeland; C Tysk; G Järnerot; K Kett; E Lindberg; D Danielsson; S N Andersen; P Brandtzaeg
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

Review 2.  Immunity, infection, and nasal disease.

Authors:  S H Yoshida; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

3.  Immunoglobulins in nasal secretions of patients with allergic rhinitis and chronic rhinosinusitis.

Authors:  Chung-Han Hsin; Chia-Tung Shun; Chia-Ming Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-08       Impact factor: 2.503

4.  Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes.

Authors:  J A Rump; D Jakschiess; U Walker; M Schlesier; P von Wussow; H H Peter
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

5.  Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency.

Authors:  D E Nilssen; P Brandtzaeg; S S Frøland; O Fausa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

Review 6.  The B-cell system of human mucosae and exocrine glands.

Authors:  P Brandtzaeg; I N Farstad; F E Johansen; H C Morton; I N Norderhaug; T Yamanaka
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.